$2.451
0.001[0.04%]
Last update: 8:19AM Get Real Time Here
Heron Therapeutics
(NASDAQ:HRTX)Latest News for Heron Therapeutics Stock (NASDAQ:HRTX)
Heron Therapeutics Stock (NASDAQ: HRTX)
Categories: All
Tuesday, April 23, 2024
- Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - 5 days ago
- HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - 6 days ago
- Heron Therapeutics shares are trading higher after Capital One initiated coverage on the stock with an Overweight rating and $6 price target.Benzinga Newsdesk - 6 days ago
- Capital One Initiates Coverage On Heron Therapeutics with Overweight Rating, Announces Price Target of $6Benzinga Newsdesk - 6 days ago
Thursday, April 11, 2024
Wednesday, March 13, 2024
- Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?Vandana Singh - Mar 13, 2024, 2:41PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Mar 13, 2024, 1:31PM
- Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Mar 13, 2024, 1:18PM
- Heron therapeutics shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5.Benzinga Newsdesk - Mar 13, 2024, 8:04AM
- Needham Maintains Buy on Heron Therapeutics, Raises Price Target to $5Benzinga Newsdesk - Mar 13, 2024, 6:28AM
Tuesday, March 12, 2024
- Heron therapeutics shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY24 revenue guidance.Benzinga Newsdesk - Mar 12, 2024, 4:58PM
- Heron Therapeutics: Q4 Earnings InsightsBenzinga Insights - Mar 12, 2024, 4:50PM
- Heron Therapeutics Sees FY24 Revenue $138M-$158MBenzinga Newsdesk - Mar 12, 2024, 4:30PM
- Heron Therapeutics Q4 2023 Adj EPS $(0.07) Beats $(0.16) EstimateBenzinga Newsdesk - Mar 12, 2024, 4:15PM
- Earnings Scheduled For March 12, 2024Benzinga Insights - Mar 12, 2024, 5:35AM
Monday, March 11, 2024
Wednesday, January 24, 2024
- Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Jan 24, 2024, 1:05PM
- Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives NodVandana Singh - Jan 24, 2024, 11:47AM
- Heron Therapeutics shares are trading higher after the company announced the FDA approved its supplemental NDA for ZYNRELEF extended-release solution to expand the indication to include additional orthopedic and soft tissue procedures.Benzinga Newsdesk - Jan 24, 2024, 10:39AM
- Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Jan 24, 2024, 10:08AM
- Heron Therapeutics Receives FDA Approval Of ZYNRELEF® Indication Expansion To Include Additional Orthopedic And Soft Tissue ProceduresBenzinga Newsdesk - Jan 24, 2024, 1:59AM
Tuesday, January 09, 2024
Monday, January 08, 2024
Sunday, January 07, 2024
Wednesday, November 15, 2023
- Crude Oil Falls 2%; TJX Issues Weak Earnings OutlookLisa Levin - Nov 15, 2023, 2:30PM
- Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?Vandana Singh - Nov 15, 2023, 2:30PM
- Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 15, 2023, 2:04PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Nov 15, 2023, 12:31PM
- Dow Rises Over 100 Points; Target Posts Upbeat EarningsLisa Levin - Nov 15, 2023, 12:20PM
- US Stocks Gain; Producer Prices Fall In OctoberLisa Levin - Nov 15, 2023, 9:57AM
- Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 15, 2023, 8:07AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Nov 15, 2023, 8:06AM
- Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $4Benzinga Newsdesk - Nov 15, 2023, 7:49AM
Tuesday, November 14, 2023
- Heron Therapeutics shares are trading higher after the company reported mixed Q3 financial results and issued guidance.Benzinga Newsdesk - Nov 14, 2023, 4:42PM
- Heron Therapeutics Sees FY23 Sales $123M-$125M Vs $124.61M Est.; FY24 Sales $138M-$158M Vs $156.57M Est.Benzinga Newsdesk - Nov 14, 2023, 4:08PM
- Heron Therapeutics Q3 EPS $(0.17) Beats $(0.29) Estimate, Sales $31.43M Miss $32.75M EstimateBenzinga Newsdesk - Nov 14, 2023, 4:06PM
- Earnings Scheduled For November 14, 2023Benzinga Insights - Nov 14, 2023, 8:23AM
Monday, November 13, 2023
Tuesday, October 03, 2023
Thursday, September 28, 2023
Thursday, September 21, 2023
Thursday, August 17, 2023
Tuesday, August 15, 2023
Monday, August 14, 2023
Wednesday, July 26, 2023
Tuesday, July 25, 2023
Monday, July 24, 2023
- Heron Therapeutics shares are trading higher after the company announced a cost reduction plan and a corporate restructuring that is expected to result in cash savings of approximately $75 million through 2025.Benzinga Newsdesk - Jul 24, 2023, 2:37PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Jul 24, 2023, 1:31PM